Skip to content
For Patients
For Investigators
Partnerships
About Us
Support QLHC
Menu
For Patients
For Investigators
Partnerships
About Us
Support QLHC
Home
For Patients
Trial Matching
I-SPY Trials
About I-SPY 2 Trials
Pre June 23, 2022
Post June 23, 2022
Trial Patients Speak
Experts Explain
Metastatic Trial Search
Metastatic Trial Locations
Clinical Trial Navigator
Advocates
Patient Resources
Frequently Asked Questions
For Investigators
Clinicians Partners
Proposal Submissions
I-SPY Trials
Phase 1: Pre-ISPY
I-SPY ARDS/COVID Expansion
RECAST DCIS
I-SPY Resources
Portal Links
Partnerships
OneSource
About QLHC
Leadership
Working with us
In The News
Support QLHC
Menu
Home
For Patients
Trial Matching
I-SPY Trials
About I-SPY 2 Trials
Pre June 23, 2022
Post June 23, 2022
Trial Patients Speak
Experts Explain
Metastatic Trial Search
Metastatic Trial Locations
Clinical Trial Navigator
Advocates
Patient Resources
Frequently Asked Questions
For Investigators
Clinicians Partners
Proposal Submissions
I-SPY Trials
Phase 1: Pre-ISPY
I-SPY ARDS/COVID Expansion
RECAST DCIS
I-SPY Resources
Portal Links
Partnerships
OneSource
About QLHC
Leadership
Working with us
In The News
Support QLHC
Executive Operations Committee
Alexander Borowsky, MD
University of California Davis
Angela DeMichele, MD, MSCE
University of Pennsylvania
Christina Yau, PhD
University of California, San Francisco
Claudine Isaacs, MD
Lombardi Comprehensive Cancer Center at Georgetown University
Douglas Yee, MD
University of Minnesota
Hope Rugo, MD
University of California, San Francisco
Jane Perlmutter, MBA, PhD
Gemini Group Consultancy
Laura Esserman, MD, MBA
University of California, San Francisco
Laura van't Veer, PhD
University of California, San Francisco
Nola Hylton, PhD
University of California, San Francisco
Rebecca Shatsky, MD
niversity of California San Diego
W. Fraser Symmans, MD
MD Anderson Cancer Center
Project Oversight
Anna Barker, PhD
Co-Chair Project Oversight Group, Arizona State University
David Parkinson, MD
President, Chief Executive Officer, ESSA Pharma
Gary Kelloff, MD
Special Advisor, National Cancer Institute
Janet Woodcock, MD
FDA
Reena Philip, PhD
FDA
ShaAvhree Buckman-Garner, MD, PhD
FDA
Steve Gutman, MD, MBA
Myraqa, Illumina, Inc.
For Patients
For Investigators
Partnerships
About us
Trials
Match To Trials
I-SPY Breast Cancer Trials
– About I-SPY 2
– Pre June 23, 2022
– Post June 23, 2022
– Trial Patients Speak
– Advocates
– Metastatic Trial Search
– Metastatic Trial Locations
Menu
Match To Trials
I-SPY Breast Cancer Trials
– About I-SPY 2
– Pre June 23, 2022
– Post June 23, 2022
– Trial Patients Speak
– Advocates
– Metastatic Trial Search
– Metastatic Trial Locations
Resources
Frequently Asked Questions
Clinical Trial Navigator
Patient Resources
Menu
Frequently Asked Questions
Clinical Trial Navigator
Patient Resources
Contact Us
Contact QLHC
Menu
Contact QLHC
Donate
Support QLHC
Menu
Support QLHC
For Patients
For Investigators
Partnerships
About us
Studies
I-SPY Trials
Phase 1: Pre-ISPY
I-SPY ARDS/COVID Expansion
RECAST DCIS
I-SPY Resources
Menu
I-SPY Trials
Phase 1: Pre-ISPY
I-SPY ARDS/COVID Expansion
RECAST DCIS
I-SPY Resources
Collaborations
Partners
Proposal Submissions
Menu
Partners
Proposal Submissions
Publications
Published Manuscripts
Meeting Abstracts
Menu
Published Manuscripts
Meeting Abstracts
Contact Us
Contact QLHC
Menu
Contact QLHC
Donate
Support QLHC
Menu
Support QLHC
Investigators Portal
Portal Links
Menu
Portal Links
For Patients
For Investigators
Partnerships
About us
Partnerships
Partnerships
Proposal Submissions
Menu
Partnerships
Proposal Submissions
One Source
OneSource
Menu
OneSource
Donate
Support QLHC
Menu
Support QLHC
For Patients
For Investigators
Partnerships
About us
Our Approach
About QLHC
Leadership
Menu
About QLHC
Leadership
QLHC in the News
In The News
Menu
In The News
Working at QL
Working with us
Menu
Working with us
Contact Us
Contact QLHC
Menu
Contact QLHC
Donate
Support QLHC
Menu
Support QLHC